A phase 1b study to evaluate the blood stage antimalarial activity of a single oral dose of tafenoquine in healthy subjects experimentally infected with Plasmodium falciparum
Latest Information Update: 21 Feb 2023
Price :
$35 *
At a glance
- Drugs Tafenoquine (Primary) ; Artemether/lumefantrine; Artesunate; Atovaquone/proguanil; Piperaquine; Primaquine
- Indications Falciparum malaria
- Focus Therapeutic Use
- 16 Feb 2023 Results(n=12) assessing blood stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum published in the Clinical Infectious Diseases
- 22 Jun 2022 Results (n=6) assessing transmission blocking activity of low dose tafenoquine in healthy volunteers published in the Clinical Infectious Diseases
- 30 Oct 2020 Planned initiation date (estimated date for recruitment of the first subject) changed to 3 Nov 2020.